Search research articles
Contact Us
Filters
Showing results (151-160 of 221) with videos related to
Page
of 23
Sort By:
Annals of Surgical Oncology
|
September 10, 2022
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Jacek Glajzer, Dan Cacsire Castillo-Tong, Rolf Richter, et al.
Blood Cancer Journal
|
September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy
Sophia Gross, Jana Ihlow, Leonie Busack, et al.
Journal of Ovarian Research
|
July 31, 2023
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
Paul Jank, Jonas Leichsenring, Svenja Kolb, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-Grade Serous Tubo-ovarian Cancer
Sofya Marchenko, Niklas Goernitz, Wiebke Alina Zoern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2024
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)
Arndt Stahler, Andreas J Kind, Christine Sers, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
Tudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2025
Spatial tumor immune microenvironment as a prognostic and predictive biomarker in anti-EGFR-based maintenance for RAS wt metastatic CRC - the PanaMa (AIO KRK0212) trial
Alexej Ballhausen, Susanna Swoboda, David Horst, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading
Simon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Oncogene
|
September 26, 2020
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
Michael Rose, Angela Maurer, Julia Wirtz, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 221) with videos related to
Sort By:
Page
of 23
Annals of Surgical Oncology
|
September 10, 2022
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Jacek Glajzer, Dan Cacsire Castillo-Tong, Rolf Richter, et al.
Blood Cancer Journal
|
September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy
Sophia Gross, Jana Ihlow, Leonie Busack, et al.
Journal of Ovarian Research
|
July 31, 2023
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
Paul Jank, Jonas Leichsenring, Svenja Kolb, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-Grade Serous Tubo-ovarian Cancer
Sofya Marchenko, Niklas Goernitz, Wiebke Alina Zoern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2024
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)
Arndt Stahler, Andreas J Kind, Christine Sers, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
Tudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2025
Spatial tumor immune microenvironment as a prognostic and predictive biomarker in anti-EGFR-based maintenance for RAS wt metastatic CRC - the PanaMa (AIO KRK0212) trial
Alexej Ballhausen, Susanna Swoboda, David Horst, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading
Simon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Oncogene
|
September 26, 2020
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
Michael Rose, Angela Maurer, Julia Wirtz, et al.
Page
of 23